company background image
NEWBRY logo

Newbury Pharmaceuticals OM:NEWBRY Stock Report

Last Price

SEK 3.86

Market Cap

SEK 97.0m

7D

-3.5%

1Y

23.7%

Updated

05 Nov, 2024

Data

Company Financials +

Newbury Pharmaceuticals AB (publ)

OM:NEWBRY Stock Report

Market Cap: SEK 97.0m

Newbury Pharmaceuticals AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Newbury Pharmaceuticals
Historical stock prices
Current Share PriceSEK 3.86
52 Week HighSEK 6.24
52 Week LowSEK 2.40
Beta1.53
11 Month Change-3.02%
3 Month Change7.22%
1 Year Change23.72%
33 Year Changen/a
5 Year Changen/a
Change since IPO-69.37%

Recent News & Updates

Recent updates

Shareholder Returns

NEWBRYSE PharmaceuticalsSE Market
7D-3.5%-1.2%-1.9%
1Y23.7%37.0%21.8%

Return vs Industry: NEWBRY underperformed the Swedish Pharmaceuticals industry which returned 37% over the past year.

Return vs Market: NEWBRY exceeded the Swedish Market which returned 21.8% over the past year.

Price Volatility

Is NEWBRY's price volatile compared to industry and market?
NEWBRY volatility
NEWBRY Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement5.4%
10% most volatile stocks in SE Market10.9%
10% least volatile stocks in SE Market3.2%

Stable Share Price: NEWBRY's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: NEWBRY's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20206Lars Minorwww.newburypharma.com

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.

Newbury Pharmaceuticals AB (publ) Fundamentals Summary

How do Newbury Pharmaceuticals's earnings and revenue compare to its market cap?
NEWBRY fundamental statistics
Market capSEK 97.03m
Earnings (TTM)-SEK 15.40m
Revenue (TTM)SEK 36.83m

2.5x

P/S Ratio

-6.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NEWBRY income statement (TTM)
RevenueSEK 36.83m
Cost of RevenueSEK 20.80m
Gross ProfitSEK 16.03m
Other ExpensesSEK 31.44m
Earnings-SEK 15.40m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

Dec 11, 2024

Earnings per share (EPS)-0.64
Gross Margin43.53%
Net Profit Margin-41.83%
Debt/Equity Ratio0%

How did NEWBRY perform over the long term?

See historical performance and comparison